Sign in
4

Changes in Ownership

Spero Therapeutics, Inc. Filed Acc 0001193125-26-283209

Director acquired 10,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
THOMAS FRANK E Director 2026-06-23 Grant or award +10,000 85,000 D
Derivatives
THOMAS FRANK E Director 2026-06-23 Grant or award · Stock Option (right to buy) +20,000 20,000 D
Loading xslF345X06/ownership.xml…